Total Valuation
Voyageur Pharmaceuticals has a market cap or net worth of $16.46M. The enterprise value is $17.01M.
Market Cap$16.46M
Enterprise Value$17.01M
Share Statistics
Voyageur Pharmaceuticals has 179,475,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding179,475,860
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Voyageur Pharmaceuticals’s return on equity (ROE) is -2.82 and return on invested capital (ROIC) is -273.32%.
Return on Equity (ROE)-2.82
Return on Assets (ROA)-1.14
Return on Invested Capital (ROIC)-273.32%
Return on Capital Employed (ROCE)-2.73
Revenue Per Employee238.47
Profits Per Employee-72.09K
Employee Count49
Asset Turnover<0.01
Inventory Turnover25.11
Valuation Ratios
The current PE Ratio of Voyageur Pharmaceuticals is ―. Voyageur Pharmaceuticals’s PEG ratio is -0.11.
PE Ratio―
PS Ratio2339.21
PB Ratio21.82
Price to Fair Value21.82
Price to FCF-9.45
Price to Operating Cash Flow―
PEG Ratio-0.11
Income Statement
In the last 12 months, Voyageur Pharmaceuticals had revenue of 11.69K and earned -3.53M in profits. Earnings per share was -0.02.
Revenue11.69K
Gross Profit-1.22M
Operating Income-3.53M
Pretax Income-3.53M
Net Income-3.53M
EBITDA-3.53M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -2.89M and capital expenditures -20.54K, giving a free cash flow of -2.89M billion.
Operating Cash Flow-2.89M
Free Cash Flow-2.89M
Free Cash Flow per Share-0.02
Dividends & Yields
Voyageur Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-19.80
52-Week Price Change-56.82%
50-Day Moving Average0.06
200-Day Moving Average0.10
Relative Strength Index (RSI)63.39
Average Volume (3m)5.52K
Important Dates
Voyageur Pharmaceuticals upcoming earnings date is Aug 3, 2026, TBA (Confirmed).
Last Earnings DateApr 23, 2026
Next Earnings DateAug 3, 2026
Ex-Dividend Date―
Financial Position
Voyageur Pharmaceuticals as a current ratio of 0.33, with Debt / Equity ratio of ―
Current Ratio0.33
Quick Ratio0.30
Debt to Market Cap<0.01
Net Debt to EBITDA0.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Voyageur Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Voyageur Pharmaceuticals EV to EBITDA ratio is -7.68, with an EV/FCF ratio of -9.37.
EV to Sales2.32K
EV to EBITDA-7.68
EV to Free Cash Flow-9.37
EV to Operating Cash Flow-9.37
Balance Sheet
Voyageur Pharmaceuticals has $267.05K in cash and marketable securities with $40.00K in debt, giving a net cash position of $227.05K billion.
Cash & Marketable Securities$267.05K
Total Debt$40.00K
Net Cash$227.05K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is ―, with operating margin of -30231.56%, and net profit margin of -30231.56%.
Gross Margin―
Operating Margin-30231.56%
Pretax Margin-30231.56%
Net Profit Margin-30231.56%
EBITDA Margin-30221.87%
EBIT Margin-30231.56%
Analyst Forecast
The average price target for Voyageur Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-29.36%